Sign up to save your podcasts
Or
Share 034 | Versant closes oversubscribed sixth healthcare-focused fund
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
034 | Versant closes oversubscribed sixth healthcare-focused fund
Versant Ventures closes its newest fund, a new stem cell company is born in the MaRs Discovery District and Auven Therapeutics official pulls the plug on the KIACTA™ AA amyloidosis program. We have all this and more for you this week on Biotechnology Focus Podcast.
View all episodes
By Biotechnology FocusVersant Ventures closes its newest fund, a new stem cell company is born in the MaRs Discovery District and Auven Therapeutics official pulls the plug on the KIACTA™ AA amyloidosis program. We have all this and more for you this week on Biotechnology Focus Podcast.